Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Holders of 5% or more of AKRO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Akero Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| General Atlantic LLC | 13G/A | 8.40%6.80M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 7.90%6.28M shares | −0.60 ppfrom 8.50% | Feb 14, 20254 filings | Nov 14, 2025 | SEC |
| RTW Investments, LP | 13G/A | 7.30%5.87M shares | −2.50 ppfrom 9.80% | Feb 14, 20252 filings | Aug 14, 2025 | SEC |
| Deep Track Capital, LP | 13G | 5.50%4.40M shares | New | Oct 7, 20251 filing | Oct 7, 2025 | SEC |
| Wellington Management Group LLP | 13G | 5.30%4.25M shares | +1.00 ppfrom 4.30% | May 12, 20253 filings | Nov 12, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Akero Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 202512:19 PM ET | Price T Rowe Associates Inc | 13G/A | 4.80%3.81M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 202512:07 PM ET | Janus Henderson Group PLC | 13G/A | 7.90%6.28M shares | −0.60 ppfrom 8.50% | Sep 30, 2025 | SEC |
| Nov 12, 20259:33 AM ET | Wellington Management Group LLPand 3 others | 13G | 5.30%4.25M shares | +1.00 ppfrom 4.30% | Sep 30, 2025 | SEC |
| Oct 7, 20254:34 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.50%4.40M shares | New | Sep 30, 2025 | SEC |
| Aug 14, 202511:25 AM ET | Janus Henderson Group PLC | 13G/A | 8.50%6.74M shares | −0.40 ppfrom 8.90% | Jun 30, 2025 | SEC |
| Aug 14, 20258:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 7.30%5.87M shares | −2.50 ppfrom 9.80% | Jun 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.30%3.41M shares | −3.20 ppfrom 7.50%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20258:13 AM ET | General Atlantic LLCand 16 others | 13G/A | 8.40%6.80M shares | – | Mar 31, 2025 | SEC |
| May 14, 202512:24 PM ET | Janus Henderson Group PLC | 13G/A | 8.90%7.07M shares | +0.20 ppfrom 8.70% | Mar 31, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 7.50%5.94M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 202512:58 PM ET | Janus Henderson Group PLC | 13G/A | 8.70%6.03M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.80%6.86M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Akero Therapeutics, Inc. shares.
No Form 144 notices for Akero Therapeutics, Inc. are on file.